Discover Allurion Technologies' Q1 2025 earnings highlights, featuring a revamped B2B2C strategy, FDA progress, improved margins, and future growth plans.

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

The U.S. Digital Therapeutics Market encompasses software-driven solutions designed to prevent, manage, and treat medical conditions and diseases through evidence-based, clinically validated digital ...

Tech companies are focusing on AI products over research, say industry experts, who are sounding the alarm about safety.